Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

1. Riechelmann, R.P.
2. Srimuninnimit, V.
3. Bordonaro, R.
4. Kavan, P.
5. Di Bartolomeo, M.
6. Maiello, E.
7. Cicin, I.
8. García-Alfonso, P.
9. Chau, I.
10. Fedyanin, M.Y.
11. Martos, C.F.
12. Ter-Ovanesov, M.
13. Peeters, M.
14. Ko, Y.-J.
15. Yalcin, S.
16. Karthaus, M.
17. Aparicio, J.
18. Heinemann, V.
19. Picard, P.
20. Bury, D.
21. Drea, E.
22. Sobrero, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.CLCC.2019.05.003 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus